Viking Global Discloses Significant Stake in Oric Pharma (ORIC)

TL;DR

**Viking Global just revealed a big stake in Oric Pharma, signaling institutional interest.**

AI Summary

Viking Global Investors LP, a major investment firm, filed an SC 13G on January 30, 2024, disclosing its ownership in Oric Pharmaceuticals, Inc. (ORIC). This filing indicates that as of January 20, 2024, Viking Global holds a significant stake in ORIC's common stock. This matters to investors because it signals a notable institutional investor's confidence in Oric Pharmaceuticals, potentially influencing other investors and the stock's perception.

Why It Matters

A large institutional investor like Viking Global taking a position can be seen as a vote of confidence, potentially attracting more investment and positively impacting Oric Pharmaceuticals' stock price.

Risk Assessment

Risk Level: low — This filing indicates a significant institutional investment, generally seen as a positive signal rather than a risk.

Analyst Insight

A smart investor would research Oric Pharmaceuticals' fundamentals and recent news to understand why Viking Global took a position, and consider if it aligns with their own investment strategy.

Key Players & Entities

• Viking Global Investors LP (company) — the investment firm filing the SC 13G
• Oric Pharmaceuticals, Inc. (company) — the subject company in which Viking Global holds shares
• DAVID C. OTT (person) — a group member associated with Viking Global
• O. ANDREAS HALVORSEN (person) — a group member associated with Viking Global
• ROSE S. SHABET (person) — a group member associated with Viking Global

Forward-Looking Statements

• Oric Pharmaceuticals (ORIC) stock may experience increased trading volume due to heightened investor interest. (Oric Pharmaceuticals, Inc.) — medium confidence, target: Q1 2024
• Other institutional investors might initiate or increase their positions in ORIC, following Viking Global's lead. (Oric Pharmaceuticals, Inc.) — low confidence, target: Q2 2024

FAQ

Key Financial Figures

• $0.0001 — ame of Issuer) Common stock, par value $0.0001 per share (Title of Class of Securiti

Filing Documents

• ef20020178_sc13g.htm (SC 13G) — 347KB
• 0001140361-24-004573.txt ( ) — 349KB

(a)

Item 1(a). Name of Issuer : ORIC Pharmaceuticals, Inc. (the "Issuer")

(b)

Item 1(b) . Address of Issuer's Principal Executive Offices : 240 E. Grand Ave, 2 nd Floor South San Francisco, CA 94080

(a)

Item 2(a) . Name of Person Filing : Viking Global Investors LP ("VGI"), Viking Global Opportunities Parent GP LLC ("Opportunities Parent"), Viking Global Opportunities GP LLC ("Opportunities GP"), Viking Global Opportunities Portfolio GP LLC ("Opportunities Portfolio GP"), Viking Global Opportunities Illiquid Investments Sub-Master LP ("VGOP"), Viking Global Opportunities Drawdown GP LLC ("VGOD GP"), Viking Global Opportunities Drawdown Portfolio GP LLC ("VGOD Portfolio GP"), Viking Global Opportunities Drawdown (Aggregator) LP ("VGOD"), O. Andreas Halvorsen, David C. Ott and Rose S. Shabet (collectively, the "Reporting Persons").

(b)

Item 2(b) . Address of Principal Business Office or, if none, Residence : The business address of each of the Reporting Persons is: 600 Washington Blvd., Floor 11, Stamford, Connecticut 06901.

(c)

Item 2(c) . Citizenship : VGI is a Delaware limited partnership; Opportunities Parent, Opportunities GP, Opportunities Portfolio GP, VGOD GP, and VGOD Portfolio GP are Delaware limited liability companies; VGOP and VGOD are Cayman Islands exempted limited partnerships; O. Andreas Halvorsen is a citizen of Norway; and David C. Ott and Rose S. Shabet are citizens of the United States.

(d)

Item 2(d) . Titles of Classes of Securities : Common stock, par value $0.0001 per share ("Common Stock")

(e)

Item 2(e) . CUSIP NUMBER : 68622P109 Item 3 . If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a : (a) Broker or dealer registered under Section 15 of the Exchange Act (b) Bank as defined in Section 3(a)(6) of the Exchange Act (c) Insurance company as defined in Section 3(a)(19) of the Exchange Act (d) Investment company registered under Section 8 of the Investment Company Act of 1940 (e) Investment Adviser registered under Section 203 of the Investment Advisers Act of 1940: see Rule 13d-1(b)(1)(ii)(E) (f) Employee Benefit Plan, Pension Fund which is (g) Parent holding company, in accordance with Rule 13d-1(b)(1)(ii)(G). (h) Savings Association as defined in Section 3(b) of the Federal Deposit Insurance Act. CUSIP No. 68622P109 13G Page 14 of 21 Pages (i) Church Plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940. (j) Non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution: (k) Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). Item 4 . This Statement on Schedule 13G relates to shares of Common Stock held directly by VGOP and VGOD. VGOP owns 2,680,000 shares of Common Stock, and VGOD owns 1,320,000 shares of Common Stock. The percentages set forth herein are calculated based on 67,365,553 shares of Common Stock issued and outstanding as of January 23, 2024, as reported in the Issuer's Registration Statement on Form S-3 filed with the Securities and Exchange Commission (the "Commission") on January 26, 2024. A. VGI (a) Amount beneficially owned: 4,000,000 (b) Percent of Class: 5.9% (c) Number of shares as to wh

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of our knowledge and belief, the undersigned certify that the information set forth in this Dated: January 30, 2024 By: /s/ Scott M. Hendler Name: Scott M. Hendler on behalf of O. Andreas Halvorsen (1) By: /s/ Scott M. Hendler Name: Scott M. Hendler on behalf of David C. Ott (2) By: /s/ Scott M. Hendler Name: Scott M. Hendler on behalf of Rose S. Shabet (3) (1) Scott M. Hendler is signing on behalf of O. Andreas Halvorsen, individually and as an Executive Committee Member of VIKING GLOBAL PARTNERS LLC, on behalf of VIKING GLOBAL INVESTORS LP, and as an Executive Committee Member of VIKING GLOBAL OPPORTUNITIES PARENT GP LLC, on behalf of itself and VIKING GLOBAL OPPORTUNITIES GP LLC, VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC, VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LP, VIKING GLOBAL OPPORTUNITIES DRAWDOWN GP LLC, VIKING GLOBAL OPPORTUNITIES DRAWDOWN PORTFOLIO GP LLC and VIKING GLOBAL OPPORTUNITIES DRAWDOWN (AGGREGATOR) LP, pursuant to an authorization and designation letter dated February 9, 2021, which was previously filed with the Commission as an exhibit to a Form 13G filed by Mr. Halvorsen on February 12, 2021 (SEC File No. 005-49737). (2) Scott M. Hendler is signing on behalf of David C. Ott, individually and as an Executive Committee Member of VIKING GLOBAL PARTNERS LLC, on behalf of VIKING GLOBAL INVESTORS LP, and as an Executive Committee Member of VIKING GLOBAL OPPORTUNITIES PARENT GP LLC, on behalf of itself and VIKING GLOBAL OPPORTUNITIES GP LLC, VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC, VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LP, VIKING GLOBAL OPPORTUNITIES DRAWDOWN GP LLC, VIKING GLOBAL OPPORTUNITIES DRAWDOWN PORTFOLIO GP LLC and VIKING GLOBAL OPPORTUNITIES DRAWDOWN (AGGREGATOR) LP, pursuant to an authorization and designation letter dated February 9, 2021, which was previously filed with the Commiss

View Full Filing

View this SC 13G filing on SEC EDGAR